Education
About Us
Working with TipRanks
Follow Us
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
RESEARCH TOOLSreports
Total Valuation
ONO Pharmaceutical Co has a market cap or net worth of $5.53B. The enterprise value is $736.21B.
Market Cap$5.53B
Enterprise Value$736.21B
Share Statistics
ONO Pharmaceutical Co has 498,692,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,692,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ONO Pharmaceutical Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.32%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.32%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee126.36M
Profits Per Employee15.40M
Employee Count3,853
Asset Turnover0.46
Inventory Turnover1.98
Valuation Ratios
The current PE Ratio of ONO Pharmaceutical Co is 19.8. ONO Pharmaceutical Co’s PEG ratio is ―.
PE Ratio19.8
PS Ratio―
PB Ratio―
Price to Fair Value0.96
Price to FCF―
Price to Operating Cash Flow9.43
PEG Ratio―
Income Statement
In the last 12 months, ONO Pharmaceutical Co had revenue of 486.87B and earned 50.05B in profits. Earnings per share was 106.55.
Revenue486.87B
Gross Profit338.92B
Operating Income59.75B
Pretax Income59.33B
Net Income50.05B
EBITDA91.54B
Earnings Per Share (EPS)106.55
Cash Flow
In the last 12 months, operating cash flow was 85.02B and capital expenditures -6.14B, giving a free cash flow of 78.88B billion.
Operating Cash Flow85.02B
Free Cash Flow78.88B
Free Cash Flow per Share158.18
Dividends & Yields
ONO Pharmaceutical Co pays an annual dividend of $0.275, resulting in a dividend yield of 4.47%
Dividend Per Share$0.275
Dividend Yield4.47%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change-8.53%
50-Day Moving Average10.99
200-Day Moving Average10.74
Relative Strength Index (RSI)76.17
Average Volume (3m)78.00
Important Dates
ONO Pharmaceutical Co upcoming earnings date is Oct 30, 2025, TBA (Confirmed).
Last Earnings DateAug 1, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend DateSep 30, 2025
Financial Position
ONO Pharmaceutical Co as a current ratio of 3.07, with Debt / Equity ratio of 17.88%
Current Ratio3.07
Quick Ratio2.56
Debt to Market Cap0.18
Net Debt to EBITDA-0.63
Interest Coverage Ratio11.23
Taxes
In the past 12 months, ONO Pharmaceutical Co has paid 9.16B in taxes.
Income Tax9.16B
Effective Tax Rate0.15
Enterprise Valuation
ONO Pharmaceutical Co EV to EBITDA ratio is 7.60, with an EV/FCF ratio of 9.34.
EV to Sales1.43
EV to EBITDA7.60
EV to Free Cash Flow9.34
EV to Operating Cash Flow8.44
Balance Sheet
ONO Pharmaceutical Co has $139.98B in cash and marketable securities with $138.11B in debt, giving a net cash position of -$1.87B billion.
Cash & Marketable Securities$139.98B
Total Debt$138.11B
Net Cash-$1.87B
Net Cash Per Share-$3.75
Tangible Book Value Per Share$929.10
Margins
Gross margin is 68.74%, with operating margin of 12.27%, and net profit margin of 10.28%.
Gross Margin68.74%
Operating Margin12.27%
Pretax Margin12.19%
Net Profit Margin10.28%
EBITDA Margin18.80%
EBIT Margin13.28%
Analyst Forecast
The average price target for ONO Pharmaceutical Co is $10.35, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$10.35
Price Target Upside-15.30% Downside
Analyst ConsensusModerate Sell
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―